Aarthi S Jayraj
@JayrajAarthi
Followers
1K
Following
4K
Media
125
Statuses
2K
Gyn oncologist @NCI-AIIMS | Junior Faculty Mentor @IGCSociety | SoMe Editor @IJGConline | Focussed on breaking disparities & improving cancer care | India
National Cancer Institute
Joined August 2020
🚨Save this post 🚨 Your ultimate guide to #IGCS2025 in Cape Town! From Wi-Fi access to registration hours and everything in between, find all the key details you’ll need during the meeting. https://t.co/LaUKBiM8SM
0
1
3
🌟 A lot is happening at #IGCS2025 for the Early Career Network! From networking sessions to dedicated programming — there’s no better time to get involved and connect with your peers from around the world. 🌍💬
0
3
7
Off to Cape Town 🇿🇦 for @IGCSociety 2025! Can’t wait to connect, learn and share our work and new ideas! 🌍
0
1
4
#IJGCconversations Checkpoint Inhibitor Rechallenge in #EndometrialCancer with Dr Brian Slomovitz @GynCancerMD 🎧 https://t.co/OtIJVR63GL
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4
0
3
7
📢📢 #PSOGI2027 📢📢 🚨 FLASH REGISTRATION🚨 — 1⃣ to🔟 November, 2025 9⃣DAYS LEFT! 📍The 16th PSOGI International Congress on Peritoneal Surface Malignancies 🌍The global community comes together in India 🇮🇳 for a historic mission — Peritoneal Malignancy Moonshot : No patient
0
12
15
Super proud of you both @KapoorShagun10 @Suvidyasingh20
@IGCSociety @IJGConline @dr_seemasinghal @Nilanchali1
#GynOnc #TeamSpirit #AIIMS
Mentorship is the bridge between learning and leadership. Meet Dr. Shagun Kapoor and Dr. Suvidya Singh from India — two inspiring members of the IGCS Early Career Professionals Network who share how IGCS membership has shaped their journey through mentorship and global
0
0
2
🎗️New in #IJGConline The #NOGGO-Expression X Study explores experiences & expectations of advance directives in #GynCancer patients 🇩🇪 📊 718 pts | 49% had a directive | 18% migration background 💬 76% wished doctors initiated conversations 🌍 Multilingual, culturally sensitive
0
5
11
Early Career Survey Opportunities 👇 Cervical Cancer Prevention https://t.co/zd9d4ckCIZ Training Programs
docs.google.com
This survey examines the current status and challenges of training programs for gynecologic oncologists across countries. At IGCS 2025, the Early Career Network Workshop’s Group 3 theme is “Training...
🌟 A lot is happening at #IGCS2025 for the Early Career Network! From networking sessions to dedicated programming — there’s no better time to get involved and connect with your peers from around the world. 🌍💬
0
1
3
🎙️ New #IJGCconversations! @pedroramirezMD chats with Dr. Rebecca Kristeleit on the #PEACOCC Trial — 💉 #Pembrolizumab in #ClearCellCancer 🧬 ✨ Insights into immune response & next steps for this rare histotype! 🎧 Listen now 👉 https://t.co/rGxGmWN7IX 🌍 @HsuMd @JayrajAarthi
0
5
14
#WebinarAlert 🚨 Breaking News in #GynecologicOncology: Combining Surgical know-how and AI 🤖 🔗 All the info & registration 👉 https://t.co/BarSVJ4AtA
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows
0
9
23
Ovarian Cancer Master Session | IGCS 2025 A powerhouse session dedicated to advancing ovarian cancer care. Expect expert perspectives, new strategies, and multidisciplinary dialogue on one of the most critical areas in gynecologic oncology. 📅 Fri, Nov 7, 2025 🕒 09:15 – 10:45
0
10
17
🟢 #ICG fluorescence angiography may enhance surgical safety by guiding #bowel perfusion assessment during #OvarianCancer cytoreduction by @stephjeangill @thomasbartlMD @kfischermd @claritasantia @MMontesinos_Alb @braunchristian1 @mattmarchettiMD @yates_elisemann @jhgelissen ✨
1
12
22
Management of intravenous #leiomyomatosis: a comprehensive review of surgical and perioperative considerations 🤕 Clinical Manifestations 🔍 Diagnosis 🔪 Treatment: Surgery 🩸 Anti-coagulation 💊 Post-operative considerations: Hormonal therapy as adjuvant treatment 📌
0
4
12
#EditorsChoice Addition of #metronidazole to standard-of-care perioperative prophylaxis at the time of hysterectomy for #gynecologicmalignancies @marina_frimer 💡 https://t.co/t00nLHipQo
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society
5
5
14
Phase II study evaluates #Palbociclib in recurrent #OvarianCancer 🧬 ➡️ Modest benefit: 10.5% ORR, PFS 3.3 mo ➡️ Promising benefit in low-grade serous ovarian cancer #LGSOC ➡️ Biomarkers identified: ✅ CDKN2A deletion – sensitivity ❌ RB1 deletion / CCNE1 amplification –
0
6
20
🎧 New #IJGCconversations episode! Dr. Pedro Ramirez @pedroramirezMD speaks with Michelle D. Lightfoot @mdslightfoot about #ADCs and strategies to prevent and manage #oralmucositis 👅 in #gynonc patients. 🔊 https://t.co/ERMkjjeloZ
@HsuMd @JayrajAarthi @AndreFernandes2
0
7
19
🌸IJGC goes pink!🌸 Together, we can build a world where every life touched by #breastcancer is empowered and supported to receive the care they need everywhere.🎀 #EveryStoryIsUnique
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society
0
4
11
Join us #IJGCclub 📆16/10/2025 ⏰See you in 1️⃣ hour! Mark your calendars 📅 for an exciting #IJGCclub 💥 Endometrial carcinosarcoma without myoinvasion with Giuseppe Cucinella @Cucinella_G and Mario Leitao @leitaomd 💻 https://t.co/oGZZSpk6QG
@pedroramirezMD @HsuMd
0
2
8
Validation of comprehensive genomic profiling for prognostic and potential therapeutic molecular classification of #endometrialcancer 🧬 https://t.co/V2mfQQthIz
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert
1
6
17